Efficacy of a respiratory syncytial virus vaccine candidate in a maternal immunization model

Jorge C. G. Blanco (), Lioubov M. Pletneva, Lori McGinnes-Cullen, Raymonde O. Otoa, Mira C. Patel, Lurds R. Fernando, Marina S. Boukhvalova and Trudy G. Morrison
Additional contact information
Jorge C. G. Blanco: Sigmovir Biosystems Inc.
Lioubov M. Pletneva: Sigmovir Biosystems Inc.
Lori McGinnes-Cullen: University of Massachusetts Medical School
Raymonde O. Otoa: Sigmovir Biosystems Inc.
Mira C. Patel: Sigmovir Biosystems Inc.
Lurds R. Fernando: Sigmovir Biosystems Inc.
Marina S. Boukhvalova: Sigmovir Biosystems Inc.
Trudy G. Morrison: University of Massachusetts Medical School

Nature Communications, 2018, vol. 9, issue 1, 1-10

Abstract: Abstract Respiratory syncytial virus (RSV) is the most common cause of bronchiolitis in infants. Maternal immunization is an option to increase maternal antibody levels and protect infants from infection. Here we assess the efficacy of virus-like particle (VLP) vaccine candidates containing stabilized pre-fusion (pre-F) or post-fusion (post-F) conformations of the RSV F protein and the attachment RSV G protein in a maternal immunization model using cotton rats. VLP vaccines containing RSV F and G proteins strongly boost pre-existing RSV immunity in dams preventing their perinatal drop in immunity. Boosting is stronger for the pre-F VLP than for the post-F VLP or purified subunit F protein vaccines, giving an advantage on mothers’ protection. VLP immunization of dams provides significant protection to pups from RSV challenge and reduced pulmonary inflammation. Collectively, our results show that a VLP vaccine with RSV F and G proteins is safe and effective for maternal and adult vaccination.

Date: 2018
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/s41467-018-04216-6 Abstract (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:9:y:2018:i:1:d:10.1038_s41467-018-04216-6

Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/

DOI: 10.1038/s41467-018-04216-6

Access Statistics for this article

Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie

More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().